Benefits and risks of neoadjuvant therapy for liver metastases

Journal of Clinical Oncology

Volumn 24, Issue 31, 2006, Pages 4954-4955

  Nordlinger, Bernard ^a   Benoist, Stéphane ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADJUVANT CHEMOTHERAPY; BLEEDING; BODY MASS; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; EDITORIAL; FATTY LIVER; HOSPITALIZATION; HUMAN; LIVER INJURY; LIVER METASTASIS; LIVER SURGERY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; TREATMENT WITHDRAWAL; WOUND HEALING IMPAIRMENT; ADJUVANT THERAPY; COLORECTAL TUMOR; DRUG EFFECT; LIVER; LIVER RESECTION; LIVER TUMOR; METASTASIS; METHODOLOGY; NOTE; PATHOLOGY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FLUOROURACIL; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS;

EID: 33750961459     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.07.9244     Document Type: Editorial

References (11)

1. Bilchik AJ, Postone G, Curley SA, et al: Neoadjuvant chemotherapy for metastatic colon cancer: A cautionary note. J Clin Oncol 23:9073-9078, 2005
2. Rubbia-Brandt L, Audard V, Sartoretti P, et al: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460-466, 2004
3. Kooby DA, Fong Y, Suriawinata A, et al: Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7:1034-1044, 2003
4. Fernandez FG, Ritter J, Goodwin JW, et al: Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845-853, 2005
5. Karoui M, Penna C, Amin-Hashem M, et al: Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1-7, 2006
6. Vauthey JN, Pawlik TM, Ribero D, et al: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072, 2006
7. Parikh AA, Gentner B, Wu TT, et al: Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082-1088, 2003
8. Aloia T, Sebagh M, Plasse M, et al: Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983-4990, 2006
9. Nordlinger B, Sorbye H, Debois M, et al: Feasibility and risks of pre-operative chemotherapy with FOLFOX 4 and surgery for resectable colorectal liver metastases: Interim results of the EORTC Intergroup randomized phase III study 4093. J Clin Oncol 23:253s, 2005 (suppl 16, abstr 3528)
10. Scappaticci FA, Fehrenbacher L, Cartwright T, et al: Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 91:173-180, 2005
11. Ellis LM, Curley SA, Grothey A: Surgical resection after downsizing of colorectal liver metastasis in the era of bevacizumab. J Clin Oncol 23:4853-4855, 2005